Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat

Journal of Urology

Volumn 164, Issue 5, 2000, Pages 1807-1811

  Burchardt, T ^a,b   Burchardt, M ^a,b   Karden, J ^a,b   Buttyan, R ^a,b   Shabsigh, A ^a,b   De La Taille, A ^b   Ng, P Y ^a,b   Anastasiadis, A G ^a,b   Shabsigh, R ^a,b  

^a Columbia University ^*  (United States)

^b NONE

Author keywords

Diabetes mellitus; Endothelium; Impotence; Muscle; Rats; Smooth

Indexed keywords

STREPTOZOCIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; ENDOTHELIUM; ERECTILE DYSFUNCTION; HEMOPERFUSION; IMAGE ANALYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SMOOTH MUSCLE FIBER; VASCULARIZATION;

EID: 0033782371     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67111-X     Document Type: Article

References (42)

1. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study
2. The role of aging and chronic disease in sexual dysfunction
3. Erectile dysfunction in diabetes and hypertension
4. Assessment and management of erectile dysfunction in men with diabetes
5. Diabetic sexual dysfunction
6. Hemodynamics of penile erection
7. Mechanisms of venous leakage: A prospective clinicopathological correlation of corporal function and structure
8. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence
9. Secretory functions of the vascular endothelium
10. Role of nitric oxide in the physiology of erection
11. Nitric oxide: A physiologic mediator of penile erection
12. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
13. Endothelin: Localization, synthesis, activity, and receptor types in human penile corpus cavernosum
14. Noradrenergic innervation of the penis in control and streptozotocin-diabetic rats: Evidence of autonomic neuropathy
15. Dysfunctional penile cholinergic nerves in diabetic impotent men
16. Pathology of the penis in long-term diabetic rats
17. Autonomic nerve involvement and venous leakage in diabetic men with impotence
18. Ultrastructural changes of corpora cavernosa in vascular erectile dysfunction
19. Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/ WORdp (type II) rats with erectile dysfunction
20. The density and distribution of endothelin 1 and endothelin receptor subtypes in normal and diabetic rat corpus cavernosum
21. Experimental diabetes mellitus inhibits prostacyclin synthesis by the rat penis: Pathological implications
22. Cavernous oxygen tension and smooth muscle fibers: Relation and function
23. Comparison of anti-desmin and anti-actin staining for the computerized analysis of cavernous smooth muscle density
24. Computerized analysis of smooth muscle fibers in potent and impotent patients
25. Corporeal veno-occlusive dysfunction: Predominantly intracavernous muscular pathology
26. Trichrome staining
27. Diminished neurogenic but not pharmacological erections in the 2- to 3-month experimentally diabetic F-344 rat
28. Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model
29. Age decreases nitric oxide synthase-containing nerve fibers in the rat penis
30. Sildenafil for treatment of erectile dysfunction in men with diabetes: A randomized controlled trial. Sildenafil Diabetes Study Group
31. Clinical significance of ultrastructural findings in the corpora cavernosa of normal and impotent men
32. Ultrastructural changes in impotent penile tissue: A comparison of 65 patients
33. An analysis of the Maxi-K+ (KCa) channel in cultured human corporal smooth muscle cells
34. Diabetic penile neuropathy
35. Deterioration of the microcirculation in diabetes
36. Age-related increase in an advanced glycation end product in penile tissue
37. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions
38. Cell activation by glycated proteins AGE receptors, receptor recognition factors and functional classification of AGEs
39. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus
40. Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats
41. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications
42. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins